Clinical Trial Success at Cincinnati Children's Supports Recent US FDA Approval for First Therapy to Directly Replace a Gene in the Brain ...
A study published inClinical Cancer Research found that in patients with unresectable, locally advanced esophageal cancer, ...
In patients with unresectable, locally advanced esophageal cancer, the triple combination of radiation, chemotherapy, and immunotherapy made tumors more amenable to surgery, which was associated with ...
Childbirth, largely a physiologic process, occurs 140 million times per year. Yet, it comes with risks; one mother dies every ...
The FDA issued its first stamp of approval for a cell or gene therapy back in 2017 to Novartis' Kymriah. | The gene therapy ...
Scientists at Pennington Biomedical Research Center, along with a colleague from Peking University People's Hospital in China ...
This process drives uncontrolled tumor growth, offering fresh insights into how RAS mutations fuel cancer progression. This ...
The country boasts 15 specialized metabolic disorder clinics, primarily located in urban centers such as Buenos Aires and ...
Increlex is an FDA and EMA approved product for the treatment of severe primary insulin-like growth factor 1 deficiency ... and additional 5 specialists will focus exclusively on our metabolic ...
Reported total revenue of $10.3 million and GAAP Net Income of $0.6 million, or $0.02 per diluted shareEntered into an asset purchase agreement ...
On the occasion of the 100th anniversary of GZUCM, Wang Wei received an exclusive interview, explained his conception of the “best era” for the development of Chinese medicine, and how GZUCM resonates ...